Purchase Order 75N95022P00136
- Not listed
- The Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a $118,665 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc., a foreign-owned for-profit manufacturer, for the supply of induced pluripotent stem cell-derived human neurons and astrocytes. This award was made on a non-competitive basis to support the Antiviral Program for Pandemics' research into antivirals for neurotropic viruses,...
- This is a $124,070 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC) derived human cell products. The contract is for the delivery of iPSC-derived human neurons and astrocytes, which are biologically relevant cell types used to support biomedical...
- This is a $23,906 firm fixed price purchase order awarded to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The award is from the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is for the delivery of various iPSC-derived cell types, such as...
- This purchase order awards Fujifilm Cellular Dynamics, Inc. $349,700 for induced pluripotent stem (iPS) cell-derived differentiated cells to support the National Center for Advancing Translational Sciences within the National Institutes of Health's National Institute on Drug Abuse. The contract delivers over 300 units of various iPS cell-derived differentiated cells to develop three-dimensional tissue models of the brain. A pre-solicitation notice sought capability statements for a potential...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $135,997 firm-fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell (iPSC)-derived human midbrain floorplate dopaminergic (iCell DopaNeurons) and glutamatergic (iCell GlutaNeurons) neurons. These fully differentiated neurons will be used in a 3D in vitro circuitry model to evaluate...
- This is a $24,924.80 firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cells. The contract is for the delivery of iPSC-derived dopaminergic and glutamatergic neuronal cells to support biomedical research and drug development initiatives. No...
- This firm-fixed price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Fujifilm Cellular Dynamics, Inc. is for the delivery of 151 kits of iCell Astrocytes and approximately 190 vials of various neuronal cell types. The $583,098 contract calls for the induced pluripotent stem cell-derived differentiated cells to be shipped in three deliveries from March through April 2023 to the National Center for Advancing Translational...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Fujifilm Cellular Dynamics, Inc., a manufacturer of biologically relevant human cells derived from induced pluripotent stem (iPS) cells. The order includes 50 units of the iCell Astrocytes Kit 01434, 20 units of the iCell DopaNeurons Kit 01279, 10 units of the iCell DopaNeurons Kit 01279, and 40 units of...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The $241,459.53 contract is for the supply of various iPS cell-derived cell types, including dopaminergic, GABAergic, and glutamatergic neurons, as well as endothelial cells, to support the National Center for Advancing...
- This is a $24,061 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the foreign-owned, for-profit manufacturer Fujifilm Cellular Dynamics, Inc. The contract is for the supply of various induced pluripotent stem cell (iPSC)-derived human cell products, including cardiomyocytes, neurons, astrocytes, hepatocytes, and endothelial cells. These specialized cell lines are used in biomedical...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $287,502 firm fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell-derived neuronal and endothelial cells. The solicitation sought these cell types on a non-competitive basis from the incumbent contractor to maintain consistent data for ongoing biofabrication of three-dimensional tissue models in the Stem Cell Translations Laboratory. Performance will take place in Madison, Wisconsin over a period of two months from February 16th to April 15th, 2022. There were no set-aside designations. Funding comes from the National Institutes of Health National Center for Advancing Translational Sciences to support research and development of tissue models for drug evaluation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells | 75N95022Q00081 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 2/2/22, 8:51 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 6/13/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 3/2/22 | |
| Not listed | Not listed | $287.5k | 2/16/22 |